Original Source
Senator McCormick Tours Penn's AI Biotech Labs, Promotes Federal Funding
Accelerating Drug Development with AI
U.S. Senator David McCormick (R-Pa.) toured the University of Pennsylvania's AIRFoundry research laboratory on Friday, May 15, 2026. The lab, launched with National Science Foundation (NSF) funding, utilizes artificial intelligence (AI) to significantly accelerate advances in biomedical and drug development. Senator McCormick expressed his inspiration, stating, “Every time I come here for a visit, I leave just inspired by all the wonderful, incredible discoveries and progress.” AIRFoundry employs AI, robotics, and automation to speed up the development of RNA-based medicines, drug delivery systems, and other biotechnology applications.
Reducing Research Timelines and Costs
Researchers at AIRFoundry highlighted how AI is transforming biomedical research by enabling scientists to process large datasets, predict successful drug formulations, and automate parts of the discovery process. Jake Gardner, an assistant professor of computer science working at the lab, noted, “Years of work become weeks of work, and that’s sort of the compression that you see when you use AI to do these things.” Andrew Hanna, a bioengineering doctoral student, explained the goal is to transform the 10-year, multi-billion-dollar process of finding a drug candidate into a six-month process. This technology is expected to reduce drug discovery timelines and costs, with potential benefits extending to fields like agriculture and veterinary science.
*Source: WHYY (2026-05-16)*
Related Articles
📧 Daily Newsletter
Get the daily global news briefing in your inbox every morning.
It's still free.